India-US trade relationship to grow: US Trade Representative Michael Froman Back to News & Events List


Describing the reforms undertaken by the Indian government as work in progress, a top Obama Administration official has linked the growth in bilateral trade between the two countries to India opening up and liberalising its economy. 

Prime Minister Modi came in with a very ambitious agenda, including to improve the business environment, the Make in India initiative, the Digital India initiative," US Trade Representative Michael Froman told PTI in an exclusive interview ahead of his next week's travel to India to attend the US-India Trade Policy Forum meeting. 

There have been a number of important reforms - the Goods and Services Tax bill, the Bankruptcy Law, the creation of commercial courts, the issuance of a national IP strategy, the opening of certain sectors to investment -- that are important and help contribute to a better business environment, he said. 

However, it is a work in progress, and there continues to be issues around investment and restrictions that can be addressed in order to improve the business environment," said Froman who is scheduled to travel to Mumbai and New Delhi next week. 

One of the key architect of India-US trade relationship in the Obama Administration, Froman said India had been successful in increasing its growth rate, and is now one of the fastest growing economies in the world. 

We both care a lot about strong copyright protection and the enforcement of copyrights, and the new (Indian) National Policy includes a focus on trade secrets, which we think is important. We appreciate the process that India went through in developing its IPR Policy, he said. 

We continue to work in the pharmaceutical area, and we very much believe that there is no contradiction in promoting innovation and promoting access, Froman said. 

Asserting that the US is very much committed to the public health objective, Froman said with the government of India, the Obama Administration had talked about a whole array of issues about access to medicines, including tariffs on imported medicine and opening up the health services market so that there are more providers in the market. 

We try to take a holistic approach to this, he noted. 

The US Food and Drug Administration (FDA) has a very high safety standards, he said, when asked about the delay in FDA's clearances for Indian drug and pharma companies. 

We do not compromise that for anybody. The primary mandate of the FDA is safety. I'm sure it is a process that takes some concerted effort, but at the end of the day, it means that Indian firms will be meeting a very high standard, he observed.

Original Source: economictimes.indiatimes.com


Recent News


11

08/2018
India-Myanmar border opens for trade

India's border with Myanmar was formally opened on Wednesday to facilitate trade between the two countries, officials said.   A function was held in the morning on...

26

07/2018
India extends $200 million credit lines to Rwanda; PM Modi holds talks with President Kagame

India on Monday extended $200 million lines of credit to Rwanda as Prime Minister Narendra Modi held wide-ranging talks with President Paul Kagame and discussed measures to st...

10

07/2018
India does not subsidise exports, complies with WTO norms: Suresh Prabhu

Dispelling the misconception that India subsidises its exports, Commerce Minister Suresh Prabhu today asserted that the country fully complies with the guidelines of the...

21

06/2018
India Says US Trade Preference Program Enhances Pace Of Economic Reforms

 India today told the Trump administration that the Generalized System of Preference program (GSP) would enhance India's development and the pace of economic reforms, ...